MOC Eligible Activity

Mineralocorticoid Receptor Antagonists: Addressing Residual Risk in Patients with Cardiac Disease, T2DM, and CKD – Webcourse
Credits 1.00 (60 min)
Format Webcourse
Starts: Dec 20, 2022
Expires: Dec 20, 2023
Mineralocorticoid Receptor Antagonists: Addressing Residual Risk in Patients with Cardiac Disease, T2DM, and CKD – Webcourse
Learn MoreMineralocorticoid Receptor Antagonists: Addressing Residual Risk in Patients with Cardiac Disease, T2DM, and CKD – Webcourse
Credits 1.00 (60 min)
Format Webcourse
Starts: Dec 20, 2022
Expires: Dec 20, 2023
© 2021 Rockpointe Corporation
© 2021 Rockpointe Corporation